NCT05386277View on ClinicalTrials.gov

A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter

NARecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

January 11, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions
Arterial Thromboembolism
Interventions
DEVICE

TufTex Single Lumen Embolectomy Catheter

The SLC Embolectomy Catheter is indicated for the removal of arterial emboli and thrombi

Trial Locations (3)

Unknown

RECRUITING

Ziekenhuis Oost-Limburg, Genk

RECRUITING

Andrej Udelnow, Brandenburg

NOT_YET_RECRUITING

Giorgio Prouse, Lugano

Sponsors

Lead Sponsor

LeMaitre Vascular

Collaborators (1)

Avania
All Listed Sponsors
collaborator

Avania

INDUSTRY

lead

LeMaitre Vascular

INDUSTRY

NCT05386277 - A PMCF Study to Confirm the Performance and Safety of the LeMaitre® TufTex Single Lumen Embolectomy Catheter | Biotech Hunter | Biotech Hunter